(Yicai Global) July 16 -- The Chinese arm of Germany's pharmaceutical giant Bayer will join hands with Ysbang, a Chinese business-to-business drug trading platform, to promote the former's medicine in Chinese third and fourth-tier cities. 

Bayer China and Shudao Information Technology, the firm behind Ysbang, penned a cooperation agreement, the Beijing Youth Daily reported today.

Bayer hopes to establish a more accurate, effective, and sustainable marketing system with Ysbang to bring its medicine closer to clients, He Yong, vice-president, head of marketing and innovation of Bayer Consumer Health China, told the same news source. 

Ysbang has an inventory worth CNY10 billion (USD1.5 billion) and by the end of last year, it covered more than 200,000 drug outlets with the volume of monthly orders exceeding 1 million, Chief Executive Zhang Buzhen of the Guangzhou-based firm said. 

Editor: Emmi Laine